These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hemorheologic considerations in the pathogenesis of vascular occlusive events in polycythemia vera. Pearson TC Semin Thromb Hemost; 1997; 23(5):433-9. PubMed ID: 9387202 [TBL] [Abstract][Full Text] [Related]
5. Hyperviscosity in polycythemia vera and other red cell abnormalities. Kwaan HC; Wang J Semin Thromb Hemost; 2003 Oct; 29(5):451-8. PubMed ID: 14631544 [TBL] [Abstract][Full Text] [Related]
7. Chorea in polycythemia vera: a rare presentation of hyperviscosity. Cohen AM; Gelvan A; Yarmolovsky A; Djaldetti M Blut; 1989 Jan; 58(1):47-8. PubMed ID: 2917203 [TBL] [Abstract][Full Text] [Related]
8. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia. Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481 [TBL] [Abstract][Full Text] [Related]
9. [Blood viscosity in patients with polycythemia vera with neurological symptoms]. Holte W Ugeskr Laeger; 1968 Aug; 130(31):1259-68. PubMed ID: 5701586 [No Abstract] [Full Text] [Related]
10. Polycythemia rubra vera and conjunctival vascular congestion. Lindsey J; Insler MS Ann Ophthalmol; 1985 Jan; 17(1):62-3. PubMed ID: 3977220 [TBL] [Abstract][Full Text] [Related]
11. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments. De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T; Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279 [TBL] [Abstract][Full Text] [Related]
12. Correlation between retinal microcirculation and blood viscosity in patients with hyperviscosity syndrome. Dobberstein H; Solbach U; Weinberger A; Wolf S Clin Hemorheol Microcirc; 1999; 20(1):31-5. PubMed ID: 11185681 [TBL] [Abstract][Full Text] [Related]
13. Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia. Michiels JJ; Berneman Z; Schroyens W; van Urk H Ann Hematol; 2003 Mar; 82(3):153-9. PubMed ID: 12634947 [TBL] [Abstract][Full Text] [Related]
14. [Clinical aspects and therapy of hyperviscosity syndrome. Clinical, viscosimetric and plethysmographic studies on the efficacy and duration of the effects of erythrocytapheresis and plasmapheresis in polycythemia vera and monoclonal gammopathies]. van den Berg E; Haedicke C; Sgries B; Stangel W; Altmann S; Hartmann F Vasa Suppl; 1983; 10():1-37. PubMed ID: 6340361 [No Abstract] [Full Text] [Related]
15. Myocardial ischemia in Vaquez's disease. Ponte E; Melato M; Falconieri G Morphol Embryol (Bucur); 1984; 30(3):185-9. PubMed ID: 6239095 [TBL] [Abstract][Full Text] [Related]
16. Blood is thicker than water: the management of hyperviscosity in adults with cyanotic heart disease. DeFilippis AP; Law K; Curtin S; Eckman JR Cardiol Rev; 2007; 15(1):31-4. PubMed ID: 17172881 [TBL] [Abstract][Full Text] [Related]
17. Blood viscosity studies in native and reconstituted polycythemic blood. Procidano M; Zanolli FA; Fornasiero L; Girolami A Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):671-80. PubMed ID: 6083942 [TBL] [Abstract][Full Text] [Related]
20. Neonatal whole blood hyperviscosity: the important factor influencing later neurologic function is the viscosity and not the polycythemia. Drew JH; Guaran RL; Cichello M; Hobbs JB Clin Hemorheol Microcirc; 1997; 17(1):67-72. PubMed ID: 9181760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]